These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11115734)

  • 1. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice.
    Kuzmin AV; Gerrits MA; Zvartau EE; van Ree JM
    Eur Neuropsychopharmacol; 2000 Dec; 10(6):447-54. PubMed ID: 11115734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys.
    Mello NK; Kamien JB; Lukas SE; Drieze J; Mendelson JH
    Neuropsychopharmacology; 1993 Jan; 8(1):45-55. PubMed ID: 8381011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.
    Smith MA; Gordon KA; Craig CK; Bryant PA; Ferguson ME; French AM; Gray JD; McClean JM; Tetirick JC
    Psychopharmacology (Berl); 2003 May; 167(3):265-73. PubMed ID: 12669175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure.
    Oliveto A; Sevarino K; McCance-Katz E; Feingold A
    Pharmacol Biochem Behav; 2002; 71(1-2):85-96. PubMed ID: 11812511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Morgan D; Picker MJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of buprenorphine in the rat.
    Holtzman SG
    Psychopharmacology (Berl); 1997 Apr; 130(3):292-9. PubMed ID: 9151365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution and primary dependence studies in animals.
    Woods JH; Gmerek DE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM; McNiel DM
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys.
    Winger G; Skjoldager P; Woods JH
    J Pharmacol Exp Ther; 1992 Apr; 261(1):311-7. PubMed ID: 1560376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.
    Walsh SL; Geter-Douglas B; Strain EC; Bigelow GE
    J Pharmacol Exp Ther; 2001 Oct; 299(1):147-58. PubMed ID: 11561074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of repeated opioid administration on locomotor activity: II. Unidirectional cross-sensitization to cocaine.
    Smith MA; Greene-Naples JL; Felder JN; Iordanou JC; Lyle MA; Walker KL
    J Pharmacol Exp Ther; 2009 Aug; 330(2):476-86. PubMed ID: 19403852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
    Vivian JA; DeYoung MB; Sumpter TL; Traynor JR; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Jul; 290(1):259-65. PubMed ID: 10381785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor.
    Smith MA; Chisholm KA; Bryant PA; Greene JL; McClean JM; Stoops WW; Yancey DL
    Psychopharmacology (Berl); 2005 Aug; 181(1):27-37. PubMed ID: 15778888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
    Fischer BD; Dykstra LA
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.
    Bidlack JM
    Adv Pharmacol; 2014; 69():387-418. PubMed ID: 24484983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of buprenorphine, nalbuphine and butorphanol alone or following halothane anaesthesia on food and water consumption and locomotor movement in rats.
    Liles JH; Flecknell PA
    Lab Anim; 1992 Jul; 26(3):180-9. PubMed ID: 1501431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
    Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men.
    Goletiani NV; Mendelson JH; Sholar MB; Siegel AJ; Mello NK
    Pharmacol Biochem Behav; 2009 Feb; 91(4):526-36. PubMed ID: 18848957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.